COPD SYMPOSIUM 2020- ADVANCES IN COPD TREATMENT

Chronic Obstructive Pulmonary Disease (COPD) is a debilitating disease with increasing morbidity and mortality worldwide. The main goal of therapy is symptomatic relief and improvement of quality of life through different medical treatment. However, such therapies cannot reverse or significantly reduce hyperinflation leaving patients with poor quality of life. In a selected subgroup of patients with predominant emphysema and hyperinflation, bronchial valve therapy represents a further treatment option, recently approved by the FDA. Recently, trials have also focused on bronchoscopic treatment of chronic bronchitis. The purpose is to provide a comprehensive summary of the currently available clinical trials, discuss common complications and their management as well as evaluation of proper patient selection in clinical practice.

LEARNING OBJECTIVES

Upon completion of this activity, participants will be able to:

TARGET AUDIENCE

This course is targeted to Primary Care Physicians, Specialty Physicians, Nurse Practitioners, and Physician Assistants. This course may also be of interest to physicians who practice in Internal Medicine, Pulmonary Medicine, and Thoracic Surgery.

COURSE DIRECTORS

Fayez Kheir, MD, Msc
IP Director, Anna Jacques Hospital, Interventional Pulmonology Clerkship
Director, Beth Israel Deaconess Medical Center

Adnan Majid, MD
Director and Chief, ​Interventional Pulmonology, Beth Israel Deaconess Medical Center
Associate Professor of Medicine, Harvard Medical School